NEURAL REGULATION AND PHYSIOLOGIC ACTIONS OF THE APP FAMILY OF PROTEINS

APP 蛋白质家族的神经调节和生理作用

基本信息

  • 批准号:
    6234439
  • 负责人:
  • 金额:
    $ 14.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-04-15 至 1998-03-31
  • 项目状态:
    已结题

项目摘要

The nature of the genetic mutations associated with AD strongly suggest that an abnormality in the expression or processing of the amyloid precursor protein (APP) leads to AD pathology. How might aging itself, which underlies the vast majority of AD cases, lead to a similar pathology? Recent in vitro evidence establishes that secreted fragments of APP, APPS, improve neuronal CA ++ homeostasis and promote neuronal survival; secreted ABeta has opposite effects. A disruption of this balance, between the neurotoxic ABeta and the neuroprotective APPS, now seems a compelling mechanism which might contribute to AD pathology. Homologous proteins, the amyloid precursor-like proteins (APLPs), likely have functional and pathophysiologic roles in APP biology as well. Using electrophysiologic recording techniques, fluorescent Ca++ -indicator dyes and neurotoxicity assays, we have designed experiments to examine how APPs and APLPs and APLPs modulate important processes involved in Ca++ homeostasis including: voltage-dependent calcium channels, robust synaptic activity, glutamate-receptor activation and Ca++ release from internal stores. Since APPs, ABeta, and APLPs are secreted, present in synaptic terminals, modulate intraneuronal [Ca++], and are neuroprotective in excitotoxicity models, we suspect they play an important role in synaptic transmission. To test this, we plan to examine the effects of APPs and APLPs in a model system that exhibits easily controlled synaptic activity. Known mechanisms of APP regulation in non-neural tissues combined with newly found functional properties, strongly suggest that the synthesis and secretion of the APP family of proteins are regulated by inherently neural processes. In this proposal we plan to carefully examine the effects of neurotransmitter-receptor activation, thermal and metabolic neural stress, and activated second messenger systems on APP, APPs, ABeta and APLP synthesis and secretion. Our preliminary data indicate that a variety of physiologically important conditions differentially affect APP, APPs and APLP levels in neurons and glia and their overlying media. Aging-related disorders, like genetic mutations, could alter the functional activity, processing or synthesis of these molecules contributing to AD neurodegeneration. To study effects due to aging itself, we will compare regulatory and functional properties of the APP family of proteins in mature, month old cultures with cultures grown for greater than 6 months. Our goal is to discover how the functional properties and regulation of the various members of the APP family of molecules are coordinated in normal and stressed CNS tissue. Our central hypothesis is that a disorder in this relationship could adversely affect neuronal Ca++ homeostasis and thereby contribute to neurodegeneration in AD.
与AD相关的基因突变的性质强烈表明, 淀粉样蛋白的表达或加工异常 前体蛋白(APP)导致AD病理。 衰老本身, 这是绝大多数AD病例的基础,导致类似的 病理学 最近的体外证据表明,分泌的片段 APP、APPS,改善神经元CA ++稳态,促进神经元CA ++稳态, 存活;分泌的ABeta具有相反的效果。 破坏这一点 平衡,在神经毒性ABeta和神经保护APPS之间,现在 似乎是一个令人信服的机制,可能有助于AD病理。 同型半胱氨酸蛋白,淀粉样蛋白受体样蛋白(APLPs),可能 在APP生物学中也具有功能和病理生理作用。 使用 电生理记录技术,荧光Ca++指示染料 和神经毒性测定,我们设计了实验来研究如何 APPs和APLPs和APLPs调节Ca++参与的重要过程 稳态包括:电压依赖性钙通道,稳健 突触活动、谷氨酸受体激活和Ca++释放 内部存储。 由于APPs、ABeta和APLPs是分泌的,存在于 突触终末,调节神经元内[Ca++], 在兴奋性毒性模型中具有神经保护作用,我们怀疑它们发挥了 在突触传递中的重要作用。 为了验证这一点,我们计划 在一个模型系统中研究杀伤人员地雷和杀伤人员地雷的影响, 易于控制的突触活动。 非神经组织中APP调节的已知机制与 新发现的功能特性,强烈表明,合成 APP家族蛋白质的分泌受固有的 神经过程 在本提案中,我们计划仔细检查 神经递质-受体活化、热和代谢的影响 神经应激和激活的第二信使系统对APP,APP,ABeta 以及APLP的合成和分泌。 我们的初步数据显示, 各种生理上重要的条件不同地影响 神经元和神经胶质及其上覆介质中的APP、APP和APLP水平。 与衰老有关的疾病,如基因突变,可能会改变 这些分子的功能活性、加工或合成 导致AD神经变性 为了研究由于衰老 本身,我们将比较APP的监管和功能属性 蛋白质家族在成熟的,月龄的培养物中, 超过6个月。 我们的目标是发现 APP家族的各种成员的特性和调节 分子在正常和应激的CNS组织中是协调的。 我们的中央 一种假设是,这种关系中的障碍可能会对 神经元Ca++稳态,从而有助于神经变性, AD.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Walter J. Koroshetz其他文献

Low-pressure balloon angioplasty with adjuvant pharmacological therapy in patients with acute ischemic stroke caused by intracranial arterial occlusions
  • DOI:
    10.1007/s00234-007-0340-z
  • 发表时间:
    2008-01-03
  • 期刊:
  • 影响因子:
    2.600
  • 作者:
    Raul G. Nogueira;Lee H. Schwamm;Ferdinando S. Buonanno;Walter J. Koroshetz;Albert J. Yoo;James D. Rabinov;Johnny C. Pryor;Joshua A. Hirsch
  • 通讯作者:
    Joshua A. Hirsch
Unusual visual symptoms in a patient with bilateral vertebral artery dissection: A case report
  • DOI:
    10.1016/j.jemermed.2005.09.014
  • 发表时间:
    2006-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    John T. Nagurney;David Feldman;Daniel P. Cahill;Nehal M. Gatha;Walter J. Koroshetz
  • 通讯作者:
    Walter J. Koroshetz
Clinical Predictors of Significant Findings on Head Computed Tomographic Angiography
  • DOI:
    10.1016/j.jemermed.2009.08.021
  • 发表时间:
    2011-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Soheil Jamshidi;Prem A. Kandiah;Aneesh B. Singhal;Joshua B. Resnick;Karen L. Furie;Pierre Borczuk;Blair A. Parry;Michael Lev;Walter J. Koroshetz;Yuchiao Chang;John T. Nagurney
  • 通讯作者:
    John T. Nagurney

Walter J. Koroshetz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Walter J. Koroshetz', 18)}}的其他基金

Specialized Program of Translational Research in Acute Stroke at the Partners Hea
合作伙伴医院急性中风转化研究专门项目
  • 批准号:
    7320993
  • 财政年份:
    2006
  • 资助金额:
    $ 14.55万
  • 项目类别:
SCREENING TECHNOLOGY AND OUTCOMES PROJECT IN STROKE (STOPSTROKE)
STROKE(STOPSTROKE)中的筛查技术和成果项目
  • 批准号:
    7205086
  • 财政年份:
    2004
  • 资助金额:
    $ 14.55万
  • 项目类别:
Screening Technology and Outcomes Project in Stroke
中风筛查技术和结果项目
  • 批准号:
    6546064
  • 财政年份:
    2002
  • 资助金额:
    $ 14.55万
  • 项目类别:
Screening Technology and Outcomes Project in Stroke
中风筛查技术和结果项目
  • 批准号:
    6669163
  • 财政年份:
    2002
  • 资助金额:
    $ 14.55万
  • 项目类别:
Screening Technology and Outcomes Project in Stroke
中风筛查技术和结果项目
  • 批准号:
    6772408
  • 财政年份:
    2002
  • 资助金额:
    $ 14.55万
  • 项目类别:
NEURAL REGULATION AND PHYSIOLOGIC ACTIONS OF THE APP FAMILY OF PROTEINS
APP 蛋白质家族的神经调节和生理作用
  • 批准号:
    6098487
  • 财政年份:
    1998
  • 资助金额:
    $ 14.55万
  • 项目类别:
EFFECT OF RILUZOLE ON LEVELS OF BRAIN LACTATE IN PATIENT WITH HUNTINGTON'S DIS
利鲁唑对亨廷顿舞蹈症患者脑乳酸水平的影响
  • 批准号:
    6280034
  • 财政年份:
    1997
  • 资助金额:
    $ 14.55万
  • 项目类别:
EFFECT OF RILUZOLE ON LEVELS OF BRAIN LACTATE IN PATIENT WITH HUNTINGTON'S DIS
利鲁唑对亨廷顿舞蹈症患者脑乳酸水平的影响
  • 批准号:
    6250250
  • 财政年份:
    1997
  • 资助金额:
    $ 14.55万
  • 项目类别:
NEUROBIOLOGY OF HEAT SHOCK RESPONSE IN NEURONAL CULTURES
神经元培养中热休克反应的神经生物学
  • 批准号:
    2270693
  • 财政年份:
    1993
  • 资助金额:
    $ 14.55万
  • 项目类别:
BIOPHYSICAL BASIS OF GLUTAMATE AND DOPAMINE EFFECTS
谷氨酸和多巴胺作用的生物物理学基础
  • 批准号:
    3084144
  • 财政年份:
    1988
  • 资助金额:
    $ 14.55万
  • 项目类别:

相似海外基金

NOVEL RNASE PROTECTION ASSAY FOR CYTOKINE MRNAS
细胞因子 MRNAS 的新型 RNA 酶保护测定
  • 批准号:
    6317727
  • 财政年份:
    2000
  • 资助金额:
    $ 14.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了